Global Influenza Programme
We provide Member States with strategic guidance, technical support and coordination of activities essential to make their health systems better prepared against seasonal, zoonotic and pandemic influenza threats to populations and individuals.

RSV surveillance case definitions

The lack of a global uniform surveillance case definition for RSV complicates the interpretation of surveillance data. A significant fraction (often >50%) of RSV-infected young children and elderly patients present without fever. Furthermore, RSV infection often presents with signs of apnea and / or sepsis in infants less than 6 months age.

“Extended SARI” case definition for hospital-based surveillance for severe RSV infection
  • severe - defined as requiring hospitalization; and
  • acute - defined as onset within the last 10 days; and
  • respiratory infection - defined as having cough [in some sites cough or shortness of breath].
In infants less than 6 mo, additionally include those who present with
  • apnoea - defined as temporary cessation of breathing from any cause, and/or
  • sepsis - defined as
    • fever (37.5 °C or above) or hypothermia (less than 35.5 °C), and
    • shock (lethargy, fast breathing, cold skin, prolonged capillary refill, fast weak pulse), and
    • seriously ill with no apparent cause
“ARI” case definition for community-based surveillance for RSV infection
  • acute - defined as sudden onset of symptoms; and
  • respiratory infection - defined as having at least one of the following:
    • shortness of breath; cough.
    • sore throat.
    • coryza.

In the WHO RSV surveillance pilot, the use of an extended SARI or an ARI case definition substantially increased the number of RSV infections detected. These definitions do not require fever to identify a suspect case. This is also important when surveillance data are used to estimate disease burden.

The RSV case definition is not intended to replace or modify the SARI or ILI definition for influenza surveillance. In practice, the physician or nurse in a sentinel hospital engaged in both RSV and influenza surveillance, screens patients with acute onset cough or shortness of breath and collects an age-appropriate respiratory specimen. Information on the presence or absence of fever is recorded in the specimen requisition form and sent to the laboratory along with the respiratory specimen. At the laboratory, all the specimens are tested for RSV, whereas those specimens from patients with fever are additionally tested for influenza.


WHO launches phase II

WHO launches phase II of the Global Respiratory Syncytial Virus Surveillance

The 3-year extension phase (Nov 2018 – Oct 2021) aims to consolidate the achievements of the original investment and proposes to 

 

(a)  enhance the surveillance in infants and young children less than 2y,

(b)  focus on the more severe disease requiring hospitalization,

(c)  widen virologic monitoring to differentiate virus types and to identify genetic groups, and

(d)  generate a robust understanding of the seasonality, risk groups and disease burden particularly RSV-associated hospitalization burden in LMICs with a wider geographic representation in all WHO Regions. 

 

Read more on WHO RSV surveillance strategy of Phase II

Objectives

Case definitions

Sampling strategy for RSV testing

Laboratory testing